503b tirzepatide Compounders lose battle over Eli Lilly weight loss drug and FDA shortage list Apothecary 503B Tirzepatide – Experiences

Stronger satiety effects typically appear after stepping up to 0.5-1.0 mg/week

Eligibility for weight loss injections typically requires a BMI 30 kg/m or 27 kg/m with at least one weight-related complication (such as hypertension, dyslipidemia, type 2 diabetes, or MASLD)

So in order to do it effectively, you choose a day, let's say it is Sunday, something you can remember

Do not inject into areas of lipodystrophy or localized cutaneous amyloidosis [see WARNINGS AND PRECAUTIONS , and ADVERSE REACTIONS ]

Ankylosing Spondylitis Spine pain

No Do you have dexterity, vision, or tremor issues that make syringe use difficult